Mucosal transmission of pathogenic CXCR4-utilizing SHIV(SF33A) variants in rhesus macaques

Janet M. Harouse, Rei Chin How Tan, Agegnehu Gettie, Peter Dailey, Preston A. Marx, Paul A Luciw, Cecilia Cheng-Mayer

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Infection of macaques with chimeric simian/human immunodeficiency virus (SHIV) expressing the envelope protein of HIV-1 provides a model system for studying HIV-1 infection in humans. To this end, four rhesus macaques (Macaca mulatta) were given a single intravaginal (IVAG) inoculation of cell-free SHIV(SF33A) and longitudinal samples of peripheral blood and lymph nodes were analyzed for viremia, antigenemia, and various T-cell populations. Rhesus macaques infected IVAG with SHIV(SF33A) demonstrated a dramatic decrease in the CD4+ PBMC subset in the initial weeks after viral exposure, a time that corresponded to peak in plasma viremia and antigenemia. Within 4 months of SHIV(SF33A) inoculation, partial to complete rebound of the CD4+ PBMC was seen in these animals. Notably, the regeneration of the CD4+ subset was associated with regeneration of the naive T-cell population and was concordant with clearance of plasma viremia. DNA heteroduplex tracking assays revealed transmission of minor variants within the SHIV(SF33A) inoculum to the IVAG-inoculated animals. The cell-free SHIV(SF33A) inoculum as well as virus isolated from animals early after transmission used the chemokine molecule CXCR4 as the primary cellular coreceptor, demonstrating that viruses expressing envelope glycoproteins of the syncytia inducing (SI) phonotype can be transported across the vaginal mucosa. Although none of the animals has yet to develop clinical symptoms of simian AIDS (SAIDS), infectious virus and viral nucleic acids could be persistently isolated from each animal. Furthermore, animals transfused with blood from IVAG-infected macaques drawn 2 weeks after inoculation suffered a more profound and sustained CD4+ T-cell loss, persistent plasma viremia, and the development of SAIDS in one animal, indicating that IVAG-passaged SHIV(SF33A) was pathogenic. Taken together, these results establish that a pathogenic CXCR4-utilizing SHIV(SF33A) species crossed the cervicovaginal mucosa. Different courses of infection in the IVAG versus transfusion animals suggest that host-mediated responses elicited upon transmission across mucosal barriers may serve to limit viral replication and delay disease progression in the IVAG-infected animals.

Original languageEnglish (US)
Pages (from-to)95-107
Number of pages13
JournalVirology
Volume248
Issue number1
DOIs
StatePublished - Aug 15 1998

Fingerprint

Simian Immunodeficiency Virus
Macaca mulatta
HIV
Viremia
Simian Acquired Immunodeficiency Syndrome
Macaca
T-Lymphocytes
HIV-1
Regeneration
Human Immunodeficiency Virus env Gene Products
Mucous Membrane
Nucleic Acid Heteroduplexes
Viruses
Giant Cells
Infection
Chemokines
Nucleic Acids
Population
HIV Infections
Disease Progression

Keywords

  • AIDS
  • Animal models
  • Chemokine receptors
  • Pathogenesis
  • Viral transmission

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

Harouse, J. M., Tan, R. C. H., Gettie, A., Dailey, P., Marx, P. A., Luciw, P. A., & Cheng-Mayer, C. (1998). Mucosal transmission of pathogenic CXCR4-utilizing SHIV(SF33A) variants in rhesus macaques. Virology, 248(1), 95-107. https://doi.org/10.1006/viro.1998.9236

Mucosal transmission of pathogenic CXCR4-utilizing SHIV(SF33A) variants in rhesus macaques. / Harouse, Janet M.; Tan, Rei Chin How; Gettie, Agegnehu; Dailey, Peter; Marx, Preston A.; Luciw, Paul A; Cheng-Mayer, Cecilia.

In: Virology, Vol. 248, No. 1, 15.08.1998, p. 95-107.

Research output: Contribution to journalArticle

Harouse, JM, Tan, RCH, Gettie, A, Dailey, P, Marx, PA, Luciw, PA & Cheng-Mayer, C 1998, 'Mucosal transmission of pathogenic CXCR4-utilizing SHIV(SF33A) variants in rhesus macaques', Virology, vol. 248, no. 1, pp. 95-107. https://doi.org/10.1006/viro.1998.9236
Harouse, Janet M. ; Tan, Rei Chin How ; Gettie, Agegnehu ; Dailey, Peter ; Marx, Preston A. ; Luciw, Paul A ; Cheng-Mayer, Cecilia. / Mucosal transmission of pathogenic CXCR4-utilizing SHIV(SF33A) variants in rhesus macaques. In: Virology. 1998 ; Vol. 248, No. 1. pp. 95-107.
@article{4932197bd9f0460cb3a7d7c05efa9f1b,
title = "Mucosal transmission of pathogenic CXCR4-utilizing SHIV(SF33A) variants in rhesus macaques",
abstract = "Infection of macaques with chimeric simian/human immunodeficiency virus (SHIV) expressing the envelope protein of HIV-1 provides a model system for studying HIV-1 infection in humans. To this end, four rhesus macaques (Macaca mulatta) were given a single intravaginal (IVAG) inoculation of cell-free SHIV(SF33A) and longitudinal samples of peripheral blood and lymph nodes were analyzed for viremia, antigenemia, and various T-cell populations. Rhesus macaques infected IVAG with SHIV(SF33A) demonstrated a dramatic decrease in the CD4+ PBMC subset in the initial weeks after viral exposure, a time that corresponded to peak in plasma viremia and antigenemia. Within 4 months of SHIV(SF33A) inoculation, partial to complete rebound of the CD4+ PBMC was seen in these animals. Notably, the regeneration of the CD4+ subset was associated with regeneration of the naive T-cell population and was concordant with clearance of plasma viremia. DNA heteroduplex tracking assays revealed transmission of minor variants within the SHIV(SF33A) inoculum to the IVAG-inoculated animals. The cell-free SHIV(SF33A) inoculum as well as virus isolated from animals early after transmission used the chemokine molecule CXCR4 as the primary cellular coreceptor, demonstrating that viruses expressing envelope glycoproteins of the syncytia inducing (SI) phonotype can be transported across the vaginal mucosa. Although none of the animals has yet to develop clinical symptoms of simian AIDS (SAIDS), infectious virus and viral nucleic acids could be persistently isolated from each animal. Furthermore, animals transfused with blood from IVAG-infected macaques drawn 2 weeks after inoculation suffered a more profound and sustained CD4+ T-cell loss, persistent plasma viremia, and the development of SAIDS in one animal, indicating that IVAG-passaged SHIV(SF33A) was pathogenic. Taken together, these results establish that a pathogenic CXCR4-utilizing SHIV(SF33A) species crossed the cervicovaginal mucosa. Different courses of infection in the IVAG versus transfusion animals suggest that host-mediated responses elicited upon transmission across mucosal barriers may serve to limit viral replication and delay disease progression in the IVAG-infected animals.",
keywords = "AIDS, Animal models, Chemokine receptors, Pathogenesis, Viral transmission",
author = "Harouse, {Janet M.} and Tan, {Rei Chin How} and Agegnehu Gettie and Peter Dailey and Marx, {Preston A.} and Luciw, {Paul A} and Cecilia Cheng-Mayer",
year = "1998",
month = "8",
day = "15",
doi = "10.1006/viro.1998.9236",
language = "English (US)",
volume = "248",
pages = "95--107",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Mucosal transmission of pathogenic CXCR4-utilizing SHIV(SF33A) variants in rhesus macaques

AU - Harouse, Janet M.

AU - Tan, Rei Chin How

AU - Gettie, Agegnehu

AU - Dailey, Peter

AU - Marx, Preston A.

AU - Luciw, Paul A

AU - Cheng-Mayer, Cecilia

PY - 1998/8/15

Y1 - 1998/8/15

N2 - Infection of macaques with chimeric simian/human immunodeficiency virus (SHIV) expressing the envelope protein of HIV-1 provides a model system for studying HIV-1 infection in humans. To this end, four rhesus macaques (Macaca mulatta) were given a single intravaginal (IVAG) inoculation of cell-free SHIV(SF33A) and longitudinal samples of peripheral blood and lymph nodes were analyzed for viremia, antigenemia, and various T-cell populations. Rhesus macaques infected IVAG with SHIV(SF33A) demonstrated a dramatic decrease in the CD4+ PBMC subset in the initial weeks after viral exposure, a time that corresponded to peak in plasma viremia and antigenemia. Within 4 months of SHIV(SF33A) inoculation, partial to complete rebound of the CD4+ PBMC was seen in these animals. Notably, the regeneration of the CD4+ subset was associated with regeneration of the naive T-cell population and was concordant with clearance of plasma viremia. DNA heteroduplex tracking assays revealed transmission of minor variants within the SHIV(SF33A) inoculum to the IVAG-inoculated animals. The cell-free SHIV(SF33A) inoculum as well as virus isolated from animals early after transmission used the chemokine molecule CXCR4 as the primary cellular coreceptor, demonstrating that viruses expressing envelope glycoproteins of the syncytia inducing (SI) phonotype can be transported across the vaginal mucosa. Although none of the animals has yet to develop clinical symptoms of simian AIDS (SAIDS), infectious virus and viral nucleic acids could be persistently isolated from each animal. Furthermore, animals transfused with blood from IVAG-infected macaques drawn 2 weeks after inoculation suffered a more profound and sustained CD4+ T-cell loss, persistent plasma viremia, and the development of SAIDS in one animal, indicating that IVAG-passaged SHIV(SF33A) was pathogenic. Taken together, these results establish that a pathogenic CXCR4-utilizing SHIV(SF33A) species crossed the cervicovaginal mucosa. Different courses of infection in the IVAG versus transfusion animals suggest that host-mediated responses elicited upon transmission across mucosal barriers may serve to limit viral replication and delay disease progression in the IVAG-infected animals.

AB - Infection of macaques with chimeric simian/human immunodeficiency virus (SHIV) expressing the envelope protein of HIV-1 provides a model system for studying HIV-1 infection in humans. To this end, four rhesus macaques (Macaca mulatta) were given a single intravaginal (IVAG) inoculation of cell-free SHIV(SF33A) and longitudinal samples of peripheral blood and lymph nodes were analyzed for viremia, antigenemia, and various T-cell populations. Rhesus macaques infected IVAG with SHIV(SF33A) demonstrated a dramatic decrease in the CD4+ PBMC subset in the initial weeks after viral exposure, a time that corresponded to peak in plasma viremia and antigenemia. Within 4 months of SHIV(SF33A) inoculation, partial to complete rebound of the CD4+ PBMC was seen in these animals. Notably, the regeneration of the CD4+ subset was associated with regeneration of the naive T-cell population and was concordant with clearance of plasma viremia. DNA heteroduplex tracking assays revealed transmission of minor variants within the SHIV(SF33A) inoculum to the IVAG-inoculated animals. The cell-free SHIV(SF33A) inoculum as well as virus isolated from animals early after transmission used the chemokine molecule CXCR4 as the primary cellular coreceptor, demonstrating that viruses expressing envelope glycoproteins of the syncytia inducing (SI) phonotype can be transported across the vaginal mucosa. Although none of the animals has yet to develop clinical symptoms of simian AIDS (SAIDS), infectious virus and viral nucleic acids could be persistently isolated from each animal. Furthermore, animals transfused with blood from IVAG-infected macaques drawn 2 weeks after inoculation suffered a more profound and sustained CD4+ T-cell loss, persistent plasma viremia, and the development of SAIDS in one animal, indicating that IVAG-passaged SHIV(SF33A) was pathogenic. Taken together, these results establish that a pathogenic CXCR4-utilizing SHIV(SF33A) species crossed the cervicovaginal mucosa. Different courses of infection in the IVAG versus transfusion animals suggest that host-mediated responses elicited upon transmission across mucosal barriers may serve to limit viral replication and delay disease progression in the IVAG-infected animals.

KW - AIDS

KW - Animal models

KW - Chemokine receptors

KW - Pathogenesis

KW - Viral transmission

UR - http://www.scopus.com/inward/record.url?scp=0344352497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0344352497&partnerID=8YFLogxK

U2 - 10.1006/viro.1998.9236

DO - 10.1006/viro.1998.9236

M3 - Article

C2 - 9705259

AN - SCOPUS:0344352497

VL - 248

SP - 95

EP - 107

JO - Virology

JF - Virology

SN - 0042-6822

IS - 1

ER -